vs
微芯科技（MCHP）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
微芯科技的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 5.3%，领先29.2%），微芯科技同比增速更快（15.6% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -5.4%）
微芯科技（Microchip Technology）是美国知名上市半导体企业，主营微控制器、混合信号芯片、模拟芯片及闪存知识产权（Flash-IP）相关集成电路的研发、生产与销售，产品覆盖工业控制、汽车电子、消费电子、物联网等众多领域，在全球半导体细分市场拥有领先地位。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MCHP vs RPRX — 直观对比
营收规模更大
MCHP
是对方的1.9倍
$622.0M
营收增速更快
MCHP
高出10.8%
4.8%
净利率更高
RPRX
高出29.2%
5.3%
两年增速更快
RPRX
近两年复合增速
-5.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $62.7M | $214.2M |
| 毛利率 | 59.6% | — |
| 营业利润率 | 12.8% | 62.4% |
| 净利率 | 5.3% | 34.4% |
| 营收同比 | 15.6% | 4.8% |
| 净利润同比 | 217.0% | 2.9% |
| 每股收益（稀释后） | $0.06 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MCHPRPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $970.5M | $568.2M | ||
| Q4 24 | $1.0B | $593.6M | ||
| Q3 24 | $1.2B | $564.7M | ||
| Q2 24 | $1.2B | $537.3M | ||
| Q1 24 | $1.3B | $568.0M |
净利润MCHPRPRX
| Q4 25 | $62.7M | $214.2M | ||
| Q3 25 | $41.7M | $288.2M | ||
| Q2 25 | $-18.6M | $30.2M | ||
| Q1 25 | $-154.6M | $238.3M | ||
| Q4 24 | $-53.6M | $208.2M | ||
| Q3 24 | $78.4M | $544.0M | ||
| Q2 24 | $129.3M | $102.0M | ||
| Q1 24 | $154.7M | $4.8M |
毛利率MCHPRPRX
| Q4 25 | 59.6% | — | ||
| Q3 25 | 55.9% | — | ||
| Q2 25 | 53.6% | — | ||
| Q1 25 | 51.6% | — | ||
| Q4 24 | 54.7% | — | ||
| Q3 24 | 57.4% | — | ||
| Q2 24 | 59.4% | — | ||
| Q1 24 | 59.6% | — |
营业利润率MCHPRPRX
| Q4 25 | 12.8% | 62.4% | ||
| Q3 25 | 7.8% | 70.1% | ||
| Q2 25 | 3.0% | 36.3% | ||
| Q1 25 | -10.3% | 94.0% | ||
| Q4 24 | 3.0% | 60.9% | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 17.7% | 50.2% | ||
| Q1 24 | 19.1% | -13.0% |
净利率MCHPRPRX
| Q4 25 | 5.3% | 34.4% | ||
| Q3 25 | 3.7% | 47.3% | ||
| Q2 25 | -1.7% | 5.2% | ||
| Q1 25 | -15.9% | 41.9% | ||
| Q4 24 | -5.2% | 35.1% | ||
| Q3 24 | 6.7% | 96.3% | ||
| Q2 24 | 10.4% | 19.0% | ||
| Q1 24 | 11.7% | 0.8% |
每股收益（稀释后）MCHPRPRX
| Q4 25 | $0.06 | $0.49 | ||
| Q3 25 | $0.03 | $0.67 | ||
| Q2 25 | $-0.09 | $0.07 | ||
| Q1 25 | $-0.29 | $0.55 | ||
| Q4 24 | $-0.10 | $0.46 | ||
| Q3 24 | $0.14 | $1.21 | ||
| Q2 24 | $0.24 | $0.23 | ||
| Q1 24 | $0.29 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $250.7M | $618.7M |
| 总债务越低越好 | $5.4B | $9.0B |
| 股东权益账面价值 | $6.6B | $9.7B |
| 总资产 | $14.3B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.82× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MCHPRPRX
| Q4 25 | $250.7M | $618.7M | ||
| Q3 25 | $236.8M | $938.9M | ||
| Q2 25 | $566.5M | $631.9M | ||
| Q1 25 | $771.7M | $1.1B | ||
| Q4 24 | $586.0M | $929.0M | ||
| Q3 24 | $286.1M | $950.1M | ||
| Q2 24 | $315.1M | $1.8B | ||
| Q1 24 | $319.7M | $843.0M |
总债务MCHPRPRX
| Q4 25 | $5.4B | $9.0B | ||
| Q3 25 | $5.4B | $8.9B | ||
| Q2 25 | $5.5B | $8.0B | ||
| Q1 25 | $5.6B | $7.6B | ||
| Q4 24 | $6.7B | $7.6B | ||
| Q3 24 | $6.4B | $7.6B | ||
| Q2 24 | $6.2B | $7.6B | ||
| Q1 24 | $6.0B | $6.1B |
股东权益MCHPRPRX
| Q4 25 | $6.6B | $9.7B | ||
| Q3 25 | $6.7B | $9.6B | ||
| Q2 25 | $6.9B | $9.5B | ||
| Q1 25 | $7.1B | $9.8B | ||
| Q4 24 | $6.0B | $10.3B | ||
| Q3 24 | $6.3B | $10.3B | ||
| Q2 24 | $6.4B | $9.8B | ||
| Q1 24 | $6.7B | $9.9B |
总资产MCHPRPRX
| Q4 25 | $14.3B | $19.6B | ||
| Q3 25 | $14.5B | $19.3B | ||
| Q2 25 | $15.0B | $18.3B | ||
| Q1 25 | $15.4B | $17.6B | ||
| Q4 24 | $15.6B | $18.2B | ||
| Q3 24 | $15.6B | $18.0B | ||
| Q2 24 | $15.8B | $17.7B | ||
| Q1 24 | $15.9B | $16.1B |
负债/权益比MCHPRPRX
| Q4 25 | 0.82× | 0.92× | ||
| Q3 25 | 0.80× | 0.93× | ||
| Q2 25 | 0.80× | 0.84× | ||
| Q1 25 | 0.80× | 0.78× | ||
| Q4 24 | 1.12× | 0.74× | ||
| Q3 24 | 1.02× | 0.74× | ||
| Q2 24 | 0.96× | 0.78× | ||
| Q1 24 | 0.90× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $341.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $318.9M | — |
| 自由现金流率自由现金流/营收 | 26.9% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | 5.44× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $819.9M | — |
8季度趋势，按日历期对齐
经营现金流MCHPRPRX
| Q4 25 | $341.4M | $827.1M | ||
| Q3 25 | $88.1M | $702.6M | ||
| Q2 25 | $275.6M | $364.0M | ||
| Q1 25 | $205.9M | $596.1M | ||
| Q4 24 | $271.5M | $742.5M | ||
| Q3 24 | $43.6M | $703.6M | ||
| Q2 24 | $377.1M | $658.2M | ||
| Q1 24 | $430.0M | $664.6M |
自由现金流MCHPRPRX
| Q4 25 | $318.9M | — | ||
| Q3 25 | $51.6M | — | ||
| Q2 25 | $257.7M | — | ||
| Q1 25 | $191.7M | — | ||
| Q4 24 | $253.4M | — | ||
| Q3 24 | $22.8M | — | ||
| Q2 24 | $304.2M | — | ||
| Q1 24 | $389.9M | — |
自由现金流率MCHPRPRX
| Q4 25 | 26.9% | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 24.0% | — | ||
| Q1 25 | 19.8% | — | ||
| Q4 24 | 24.7% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 24.5% | — | ||
| Q1 24 | 29.4% | — |
资本支出强度MCHPRPRX
| Q4 25 | 1.9% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 5.9% | — | ||
| Q1 24 | 3.0% | — |
现金转化率MCHPRPRX
| Q4 25 | 5.44× | 3.86× | ||
| Q3 25 | 2.11× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 0.56× | 1.29× | ||
| Q2 24 | 2.92× | 6.45× | ||
| Q1 24 | 2.78× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MCHP
| Mixed Signal Microcontrollers | $586.5M | 49% |
| Analog | $322.9M | 27% |
| Other Product Line | $276.6M | 23% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
